Platelet Dysfunction
32
3
3
20
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 32 trials
100.0%
+13.5% vs benchmark
13%
4 trials in Phase 3/4
20%
4 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (32)
Influence of Oxygenator Selection on Platelet Function and Rotational Thromboelastometry Following Cardiopulmonary Bypass
Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets
Platelet Function After Cardiac Surgery.
Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
CES1 Crossover Trial of Clopidogrel and Ticagrelor
The Influence of Tramadol on Platelet Function
The Effect of Dapagliflozin on Platelet Function testinG Profiles in Diabetic PatiEnts.
The Effect of Cocoa on Platelet Function Profiles in Patients
CES1 Carriers in the PAPI Study
Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)
Correcting Platelet Dysfunction After Traumatic Brain Injury
PTRG-DES Consortium
Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial
Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation
Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets
Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM
Clinical Performance Evaluation of T-TAS 01 PL Chip